Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Epidemiology & social costs of haemophilia in India.

Kar A, Phadnis S, Dharmarajan S, Nakade J.

Indian J Med Res. 2014 Jul;140(1):19-31. Review.

2.

Triple inhibition of EGFR, Met, and VEGF suppresses regrowth of HGF-triggered, erlotinib-resistant lung cancer harboring an EGFR mutation.

Nakade J, Takeuchi S, Nakagawa T, Ishikawa D, Sano T, Nanjo S, Yamada T, Ebi H, Zhao L, Yasumoto K, Matsumoto K, Yonekura K, Yano S.

J Thorac Oncol. 2014 Jun;9(6):775-83. doi: 10.1097/JTO.0000000000000170.

3.

Impact of genetic counselling? The potential utility of haemophilia surveillance data in developing countries.

Nakade J, Potnis-Lele M, Kar A.

Haemophilia. 2013 Nov;19(6):e388-90. doi: 10.1111/hae.12255. Epub 2013 Aug 28. No abstract available.

PMID:
23992297
4.

mTOR inhibitors control the growth of EGFR mutant lung cancer even after acquiring resistance by HGF.

Ishikawa D, Takeuchi S, Nakagawa T, Sano T, Nakade J, Nanjo S, Yamada T, Ebi H, Zhao L, Yasumoto K, Nakamura T, Matsumoto K, Kagamu H, Yoshizawa H, Yano S.

PLoS One. 2013 May 14;8(5):e62104. doi: 10.1371/journal.pone.0062104. Print 2013.

5.

Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells.

Yamada T, Takeuchi S, Nakade J, Kita K, Nakagawa T, Nanjo S, Nakamura T, Matsumoto K, Soda M, Mano H, Uenaka T, Yano S.

Clin Cancer Res. 2012 Jul 1;18(13):3592-602. doi: 10.1158/1078-0432.CCR-11-2972. Epub 2012 May 2.

6.

Matrix metalloproteinase-9 contributes to kindled seizure development in pentylenetetrazole-treated mice by converting pro-BDNF to mature BDNF in the hippocampus.

Mizoguchi H, Nakade J, Tachibana M, Ibi D, Someya E, Koike H, Kamei H, Nabeshima T, Itohara S, Takuma K, Sawada M, Sato J, Yamada K.

J Neurosci. 2011 Sep 7;31(36):12963-71. doi: 10.1523/JNEUROSCI.3118-11.2011.

7.

[Study of monocyte function in patients with cervical cancer by using T-lymphocyte monocyte interaction in response to phytohemagglutinin (author's transl)].

Umesaki N, Nakade J, Nakamori H, Sako H, Lee T, Sugawa T.

Acta Obstet Gynaecol Jpn. 1981 May;33(5):664-70. Japanese.

PMID:
6972146
8.

The prognostic value of serum immunosuppressive effect in patients with ovarian cancer.

Ueda K, Toyokawa M, Nakamori H, Sako H, Umesaki N, Nakade J, Lee T, Sugawa T.

Obstet Gynecol. 1979 Apr;53(4):480-3.

PMID:
440651
9.

Immunosuppressive effect of serum in patients with ovarian carcinoma.

Ueda K, Toyokawa M, Nakamori H, Sako H, Umesaki N, Nakade J, Lee T, Sugawa T.

Obstet Gynecol. 1978 Feb;51(2):225-8.

PMID:
304546
10.

Immuno-diagnosis of ovarian cancer by the aid of cell-mediated immunologic techniques.

Ueda K, Toyokawa M, Nakamori H, Sako H, Umesaki N, Nakade J, Lee T, Sugawa T.

Osaka City Med J. 1977;23(1):73-84. No abstract available.

PMID:
345183

Supplemental Content

Loading ...
Support Center